2024-08-06 17:06:52
The result of close collaboration between Moroccan know-how in the pharmaceutical industry and the best international expertise, the Smart Factory was built on an area of 12,000 m2 and required a total investment of more than 300 million dirhams (MDH).
This new, fully digitalized industrial unit will enable Groupe Pharma 5 to increase its production capacity fivefold while ensuring perfect traceability of all production processes.
Thanks to the remote and real-time monitoring tools installed in all compartments of the plant built using the Shell Building technique, promoting the management of liquid flows, air quality, pressure, humidity, temperature and ensuring “Data Integrity”.
Designed in a unique innovation ecosystem that places agility at the heart of the entire design and operating process through the digitalization of processes, combined with the robotization of certain operations, the plant stands out for its ability to integrate all future technological advances, particularly in the field of artificial intelligence.
During this inauguration ceremony, also marked by the presence of the Minister of Health and Social Protection, Khalid Ait Taleb, and the Minister Delegate in charge of Investment, Convergence and Evaluation of Public Policies, Mohcine Jazouli, a memorandum of understanding was signed between the Ministry of Health and Social Protection and the Pharma 5 Group.
In a statement to the press, Mr. Ait Taleb indicated that the vision of the Smart Factory comes within the framework of the Kingdom’s orientations in terms of health and medicine sovereignty. “We must encourage the pharmaceutical industry and the production of generic medicines at a time when countries are suffering from difficulties in the supply of raw materials for the manufacture of medicines,” he said.
After welcoming the progress made by the Pharma 5 Group in terms of digitalization and development of its industrial tool, the minister called for the promotion and support of local initiatives that should contribute to the deployment of the national project for the generalization of compulsory health insurance (AMO) and its effective implementation through the facilitation of access to medicines.
“This new industrial unit is a significant contribution to the royal project of generalizing AMO and guaranteeing national health sovereignty,” declared, for her part, the general director of Pharma 5 Group, Mia Lahlou-Filali, adding that the generic medicine “Made in Morocco” is indeed a major component of the care already benefiting millions of our compatriots.
“The agreement that we are ratifying today concerns the creation of new production units for injectables, biotechnologies, new galenic forms and research and development in new therapeutic areas,” explained Ms. Lahlou-Filali, stating that “Pharma 5 is thus committed to investing no less than 300 million dirhams by 2027 and to creating a minimum of 300 direct jobs.”
Committed for 40 years to therapeutic independence and access to care for all, Pharma 5 confirms with this inauguration its rank as a pioneer in the pharmaceutical industry both in Morocco and in Africa.
With more than a billion units produced in 2022, Pharma 5 is today the leader in generic medicines in Morocco and exported to more than 40 countries, thus rising to 7th place on the African market which has no less than 1,200 international players.
2024-08-06 17:06:52